Workflow
AGILE GROUP(03383)
icon
Search documents
港股公告精选|百济神州上半年营收同比增超4成 中国海外发展前7月销售额超1300亿元
Xin Lang Cai Jing· 2025-08-06 12:09
Performance Highlights - BeiGene (06160.HK) reported a revenue of 17.518 billion yuan for the first half of the year, a year-on-year increase of 46%; product revenue was 17.36 billion yuan, up 45.8%; net profit was 450 million yuan, turning from loss to profit [2] - Uni-President China (00220.HK) achieved approximately 17.087 billion yuan in revenue for the first half, a year-on-year increase of 10.6%; net profit was about 1.287 billion yuan, up 33.2% [2] - Zhiyu City Technology (09911.HK) announced a positive profit forecast, expecting mid-term revenue of approximately 3.135 to 3.215 billion yuan, a year-on-year increase of about 38.0% to 41.5%; net profit is expected to be around 470 to 510 million yuan, a year-on-year growth of approximately 108.9% to 126.7% [2] Earnings Forecasts - New World Development Company (00086.HK) expects mid-term net profit to increase to no less than 800 million HKD year-on-year [3] - Weizhi Jinkou (02003.HK) anticipates mid-term net profit exceeding 200 million HKD, a significant increase year-on-year [3] - Wing Chan Industrial (01596.HK) forecasts mid-term net profit of approximately 48.7 million HKD, turning from loss to profit [3] - Huaxian Optoelectronics (00334.HK) expects mid-term net profit to exceed 48.8 million HKD, a year-on-year increase of over 600% [3] - Maifushi (02556.HK) predicts mid-term net profit of approximately 31.8 to 41 million HKD, turning from loss to profit [4] - Xinwei Medical-B (06609.HK) expects mid-term net profit to exceed 40 million HKD, turning from loss to profit [5] - China Nuclear Technology (00611.HK) anticipates mid-term net profit growth of over 15% [6] Earnings Warnings - Hongxing Printing Group (00450.HK) expects mid-term net loss of approximately 49 million HKD, a significant increase year-on-year [7] - Zhongyu Land (01224.HK) forecasts mid-term net loss of approximately 40 million HKD, turning from profit to loss [7] - Beihai Group (00701.HK) anticipates mid-term net loss of 36 to 40 million HKD [8] Real Estate Sales Data - China Overseas Development (00688.HK) reported cumulative contract property sales of approximately 132 billion yuan for the first seven months, a year-on-year decrease of 18.3% [9] - Yuexiu Property (00123.HK) achieved cumulative contract sales of approximately 67.506 billion yuan for the first seven months, a year-on-year increase of about 11.7% [9] - Poly Property Group (00119.HK) reported contract sales of approximately 29.5 billion yuan for the first seven months, a year-on-year decrease of 13.49% [10] - China Overseas Hongyang Group (00081.HK) reported cumulative contract sales of 18.649 billion yuan for the first seven months, a year-on-year decrease of 12.2% [10] - Jindi Commercial Real Estate (00535.HK) reported cumulative contract sales of approximately 6.98 billion yuan for the first seven months, a year-on-year decrease of 37.37% [10] - Agile Group (03383.HK) reported pre-sale amount of approximately 5.69 billion yuan for the first seven months [11] - Hongyang Real Estate (01996.HK) reported cumulative contract sales of 3.208 billion yuan for the first seven months, a year-on-year decrease of 41.6% [12] - Zhengrong Real Estate (06158.HK) reported cumulative contract sales of approximately 2.701 billion yuan for the first seven months, a year-on-year decrease of 30.6% [12] - Jingrui Holdings (01862.HK) reported cumulative contract sales of approximately 571 million yuan for the first seven months, a year-on-year decrease of 52.54% [13] Company News - CITIC Securities (06030.HK) reported that its subsidiary, Huaxia Fund, achieved revenue of 4.258 billion yuan and net profit of 1.123 billion yuan in the first half, with assets under management totaling 285.1237 billion yuan [14] - Xinyi International (00732.HK) reported a cumulative operating revenue of approximately 9.566 billion HKD for the first seven months, a year-on-year decrease of about 5.3% [15] - Heng Rui Pharmaceutical (01276.HK) received orphan drug designation from the US FDA for its injection of Rikan Trastuzumab combined with Adebali for gastric cancer or gastroesophageal junction adenocarcinoma indications [15] - Fuhong Hanlin (02696.HK) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanlikang® for active renal glomerulonephritis in China [15] - China Biopharmaceutical (01177.HK) announced that its self-developed TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program for the treatment of chronic graft-versus-host disease [15] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.65 billion HKD worth of about 1.714 million shares at a price of 95.8 to 96.75 HKD [16] - Hang Seng Bank (00011.HK) spent approximately 22.6347 million HKD to repurchase 200,000 shares at a price of 112.8 to 113.6 HKD [17] - Yum China (09987.HK) repurchased approximately 6.264 million HKD worth of 16,800 shares at a price of 369.8 to 376 HKD [17]
雅居乐集团(03383)7月预售金额合计为约5.2亿元
智通财经网· 2025-08-06 10:31
截至2025年7月31日止7个月,本集团连同本集团合营公司及联营公司以及雅居乐项目的预售金额合计为 约人民币56.9亿元而对应建筑面积为约61.1万平方米;平均价为每平方米人民币9,309元。 雅居乐集团(03383)发布公告,本集团连同本集团合营公司及联营公司以及由本集团管理并以"雅居 乐"品牌销售的房地产项目(雅居乐项目)于2025年7月的预售金额合计为约人民币5.2亿元而对应建筑面积 为约5.9万平方米;平均价为每平方米人民币8,810元。 ...
雅居乐集团(03383) - 2025年7月未经审核营运数据
2025-08-06 10:08
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 截至 2025 年 7 月 31 日止七個月,本集團連同本集團合營公司及聯營公司以及雅居樂項 目的預售金額合計為約人民幣 56.9 億元而對應建築面積為約 61.1 萬平方米;平均價為 每平方米人民幣 9,309 元。 上述數據或會變更並可能與本集團按年度及半年度刊發的經審核及未經審核綜合財務報 表所呈現的數字存有差異。據此,有關數據僅供投資者參考而不作其他目的。投資者在 買賣本公司證券時務須小心謹慎,不可依賴前述已披露信息。投資者如有任何疑問應向 專業人仕或財務顧問徵求意見。 承董事會命 雅居樂集團控股有限公司 公司秘書 高梓燊 香港,2025年8月6日 * 執行董事 ** 非執行董事 # 獨立非執行董事 雅居樂集團控股有限公司 (於開曼群島註冊成立的有限公司) (股份代號:3383) 2025 年 7 月 未經審核營運數據 於本公告日期,董事會由九名成員組成:即陳卓林先生 *( 主席兼總裁 ) 、黃 ...
雅居乐集团(03383) - 补充公告关於无法表示意见之最新情况
2025-08-04 09:30
– 1 – 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 雅居樂集團控股有限公司 (於開曼群島註冊成立的有限公司) (股份代號:3383) 補充公告 關於無法表示意見之最新情況 茲提述雅居樂集團控股有限公司(「本公司」,連同其附屬公司,統稱「本集團」)日期 為2025年6月30日的公告(「該公告」)。除另有界定者外,本公告所用詞彙與該公告 所界定者具有相同涵義。 誠如該公告所披露,本公司已作出行動計劃,以減輕其流動性問題及解決無法表示 意見事宜(「行動計劃」)。 本公司謹此就行動計劃提供補充資料: (i) 本集團目前正在進行境外債務重組。於本公告日期,本集團已完成其境外債務 概況的審查、境外債務類別的劃分,並一直透過外聘法律及財務顧問積極與各 不同類別債權人接洽,以推進重組進程。結合已建立的現金流測算模型及模擬 清算分析,本集團將繼續與主要的債權人小組協商,以調整債權人對重組方案 的預期並制定具體條款。重組進程正在按預定時間表推進。本集團目前預計於 ...
雅居乐集团(03383) - 截至2025年7月31日止之股份发行人的证券变动月报表
2025-08-04 09:18
公司名稱: 雅居樂集團控股有限公司 呈交日期: 2025年8月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03383 | 說明 | 不適用 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | 本月底法定/註冊股本總額: HKD 1,000,000,000 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2 ...
异动盘点0724| 造纸板块、券商股,博彩走强;美股核电大涨,文远知行涨超5%,德州仪器跌超13%
贝塔投资智库· 2025-07-24 04:24
Group 1: Market Trends - The paper sector continues its upward trend, with Nine Dragons Paper (02689.HK) leading the gains, rising over 9% after announcing a price increase of 30 CNY/ton for corrugated paper and recycled cardboard starting August 1, reflecting an optimized supply-demand structure in the industry [1] - The brokerage sector saw collective strength, with major Chinese brokerages like Dongfang Securities (03958.HK) and Zhongyuan Securities (01375.HK) rising over 6% and 5% respectively, indicating significant capital inflow into the sector [1] - Urban Beauty (02298.HK) surged 13% as its online GMV for 2024 is projected to reach 1.57 billion CNY, marking a 100% year-on-year increase, showcasing the effectiveness of its new retail transformation [1] Group 2: Company Performance - China Duty Free Group (01880.HK) soared 17% after Macquarie's report indicated a narrowing year-on-year revenue decline from 19.5% in Q4 2024 to 11% in Q1 2025, with a stable gross margin of 33% [1] - The gaming sector experienced a broad increase, with companies like 澳博控股 (00880.HK) and 银河娱乐 (00027.HK) rising over 3%, supported by UBS data showing Macau's average daily gaming revenue in July at 683 million MOP, a 14% year-on-year increase [2] - 雍禾医疗 (02279.HK) saw a 13% increase after forming a strategic partnership with Meituan Health to build a medical-grade hair health service system [2] Group 3: Real Estate and Financing - The Hong Kong real estate sector collectively strengthened, with Country Garden (02007.HK) leading with nearly a 10% rise, driven by improved financing conditions as indicated by the People's Bank of China's report showing a recovery in real estate loan growth [3] - Meilan Airport (0357.HK) rose 10% as CITIC Securities highlighted the significance of Hainan's trade opening, which is expected to benefit the local tourism industry [3] Group 4: Gold Sector Decline - The gold sector faced pressure, with companies like 潼关黄金 (00340.HK) and 大唐黄金 (08331.HK) dropping over 4%, attributed to a decline in spot gold prices below 3,380 USD/oz, driven by reduced safe-haven appeal due to easing trade tensions [4] Group 5: US Market Highlights - Futu Holdings (FUTU.US) rose 2.82% after announcing a long-term strategic partnership with Huaxia Fund to promote the integration of traditional finance and blockchain technology [5] - Japanese automotive stocks surged, with Toyota (TM.US) and Honda (HMC.US) rising over 13% following news of a trade agreement reducing tariffs on Japanese cars [6] - Nuclear power stocks in the US saw significant gains, with Oklo Inc (OKLO.US) rising 9.21%, reflecting a growing interest in nuclear energy [5]
港股内房股震荡走高,碧桂园、雅居乐集团涨超7%
news flash· 2025-07-24 02:27
Group 1 - The Hong Kong stock market for property stocks experienced a significant upward trend, with Country Garden and Agile Group rising over 7% [1] - Greenland Hong Kong saw an increase of more than 5%, while other companies such as Midea Real Estate, Kaisa Group, Longfor Group, and Sunac China also followed suit with gains [1]
港股收评:午后强势拉升!科指大涨2.8%,稳定币、生物医药股走高
Ge Long Hui· 2025-07-15 08:41
中国2025年6月重磅宏观经济数据公布,其中Q2GDP同比5.2%超预期。港股三大指数午后持续拉升走 强,一扫早盘冲高回落行情。截止收盘,恒生科技指数一马当先,最终收涨2.8%,恒生指数、国企指 数分别上涨1.6%及1.65%。 | 代码 | 名称 | 最新价 | 涨跌额 | 涨跌幅 | | --- | --- | --- | --- | --- | | 800000 | 恒生指数 | ○ 24590.12 | +386.80 | 1:60% | | 800100 | 国企指数 | 8877.10 | +144.36 | 1.65% | | 800700 | 恒生科技指数 | 5431.29 | +147.79 | 2.80% | 盘面上,作为市场风向标的大型科技股午后持续攀升助力大市上涨,其中,阿里巴巴大涨近7%,美 团、百度涨超4%,腾讯涨3.5%,京东涨超2%;行业利好不断,稳定币概念股普遍走高,云锋金融大涨 19.5%;生物医药股全天维持强势行情;苹果概念股、软件类股、汽车股、电信股、海运股午后涨幅持 续扩大。另一方面,比特币下破11.7万美元,加密货币概念股低迷,上半年全国房地产开发投资同比跌 11 ...
港股内房股再度下探,雅居乐集团(03383.HK)跌近10%,世茂集团(00813.HK)跌近7%,富力地产(02777.HK)、远洋集团(03377.HK)、融创中国(01918.HK)、中国金茂(00817.HK)均跌超5%。
news flash· 2025-07-15 03:46
Group 1 - Hong Kong property stocks have declined again, with major companies experiencing significant drops in share prices [1] - Agile Group (03383.HK) fell nearly 10%, while Shimao Group (00813.HK) dropped nearly 7% [1] - Other companies such as R&F Properties (02777.HK), Oceanwide Holdings (03377.HK), Sunac China (01918.HK), and China Jinmao (00817.HK) all saw declines of over 5% [1]
港股收盘(07.10) | 恒指收涨0.57% 地产、金融表现强势 “反内卷”题材全天活跃
智通财经网· 2025-07-10 08:55
Market Overview - The Hong Kong stock market showed mixed performance with the Hang Seng Index rising by 0.57% to close at 24028.37 points, while the Hang Seng Tech Index fell by 0.29% to 5216.6 points. The total trading volume was 2467.28 million HKD [1] - CITIC Securities anticipates that the ongoing reform of the Hong Kong listing system will enhance the asset quality and liquidity of the market, with continued inflow of southbound funds expected [1] Blue Chip Performance - ZTO Express (02057) led blue-chip stocks with a rise of 7.36% to 148.8 HKD, contributing 7.03 points to the Hang Seng Index. Other notable performers included Longfor Group (00960) up 7.05% and Sunny Optical Technology (02382) up 6.12% [2] - Conversely, Wharf Real Estate Investment (01997) fell by 3.4%, negatively impacting the index [2] Sector Highlights - Large tech stocks exhibited mixed results, with Xiaomi down 0.87% and Tencent down 0.2%, while Alibaba rose by 0.29%. The property sector saw significant gains, particularly Longfor Group which surged nearly 85% [3] - The financial sector, including brokerages and banks, showed strong performance, with Yao Cai Securities reaching a historical high [3] Real Estate Sector - The National Development and Reform Commission emphasized the importance of high-quality urbanization and plans to increase investment in key areas, which may provide opportunities for real estate stocks [4] - Longfor Holdings announced the completion of a bond restructuring involving a total principal balance of 21.96 billion HKD, exceeding market expectations [4] Banking Sector - Chinese banks saw a rise in stock prices, with Minsheng Bank (01988) up 5.17% and Construction Bank (00939) up 3.16%. Global bank indices have also reached new highs, indicating a trend of value reassessment for banks as stable income assets [5] Brokerages - Brokerage stocks performed strongly, with Yao Cai Securities (01428) up 25.91% and Shenwan Hongyuan Hong Kong (00218) up 19.46% [5] Stablecoin Regulation - The Hong Kong Special Administrative Region's Stablecoin Regulation will take effect on August 1, 2025, with the Hong Kong Monetary Authority starting the licensing process. This is expected to enhance market dynamics [6] Apple Concept Stocks - Apple-related stocks performed well, with Sunny Optical (02382) up 6.12% and BYD Electronics (00285) up 5.6% [6] Anti-Competition Measures - The Central Financial Committee's recent meeting highlighted the need to regulate low-price competition and improve product quality, which has led to price increases in silicon wafers by 8% to 11.7% [8] Notable Stock Movements - Delin Holdings (01709) surged by 18.4% after announcing plans to convert assets into digital rights via blockchain technology [9] - Hengrui Medicine (01276) reached a new high, rising 7.11% with a target price set at 134 HKD by Citigroup, predicting a compound annual growth rate of 22% in drug sales from 2024 to 2027 [10]